DelveInsight has launched a new report on “Chronic Kidney Disease – Market Insights, Epidemiology, and Market Forecast-2030”.
DelveInsight’s “Chronic Kidney Disease – Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Chronic Kidney Disease, historical and forecasted epidemiology as well as the Chronic Kidney Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Chronic Kidney Disease Market Report:
Key benefits of the report:
Got queries? Click here to know more about the Chronic Kidney Disease Market Landscape.
Chronic Kidney Disease Overview
Chronic kidney disease (CKD) is a syndrome where there are persistent alterations in kidney structure, function, or both with implications on the health of the individual. Examples of structural abnormalities include cysts, tumors, malformations, and atrophy, which are evident on imaging. By contrast, kidney dysfunction can manifest as hypertension, edema, changes in output or quality of urine, and growth delay in children. These changes are most often recognized by increased serum levels of creatinine, cystatin C, or blood urea nitrogen. Moreover, the most common pathological manifestation of CKD, regardless of the initiating insult or disease, is some form of renal fibrosis.
Chronic Kidney Disease Market
The dynamics of the Chronic Kidney Disease market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as Bristol-Myers Squibb, Complexa, Aurinia Pharmaceuticals, Dimerix, Retrophin, Corvidia Therapeutics, Boehringer Ingelheim, Palladio Biosciences, Venglustat, Calliditas Therapeutics, Angion, Reata Pharmaceuticals, Atacicept, Astra Zeneca, Boehringer Ingelheim, FibroGen/ Astellas Pharma/ AstraZeneca, Akebia Therapeutics, GlaxoSmithKline, and others during the forecasted period 2018-2030.
Learn more by requesting for sample @ Chronic Kidney Disease Market Landscape
Chronic Kidney Disease Pipeline Therapies and Key Companies
Chronic Kidney Disease Market Drivers
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Chronic Kidney Disease Patient Share (%) Overview at a Glance
5. Chronic Kidney Disease Market Overview at a Glance
6. Chronic Kidney Disease Disease Background and Overview
7. Chronic Kidney Disease Epidemiology and Patient Population
8. Country-Specific Patient Population of Chronic Kidney Disease
9. Chronic Kidney Disease Current Treatment and Medical Practices
10. Unmet Needs
11. Chronic Kidney Disease Emerging Therapies
12. Chronic Kidney Disease Market Outlook
13. Country-Wise Chronic Kidney Disease Market Analysis (2018–2030)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Chronic Kidney Disease Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Click here to read more about Chronic Kidney Disease Market Outlook 2030
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Kritika RehaniEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/malignant-mesothelioma-market